Ticker
TCRXCompany Name
TSCAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
---|---|---|---|
6/30/2025 | $ -131.25M | -138.5% | $ 94.77M |
3/31/2025 | $ -123.79M | -160.85% | $ 76.96M |
12/31/2024 | $ -114.65M | -105.52% | $ 108.65M |
9/30/2024 | $ -110.58M | -38.23% | $ 289.27M |
6/30/2024 | $ -74.7M | -23.5% | $ 317.84M |
3/31/2024 | $ -70.05M | -16.54% | $ 423.43M |
12/31/2023 | $ -64.5M | -18.84% | $ 342.36M |
9/30/2023 | $ -57.66M | -27.97% | $ 206.12M |
6/30/2023 | $ -81.68M | -81.34% | $ 100.42M |
3/31/2023 | $ -74.5M | -63.4% | $ 117.5M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Market Cap
(=) FCF Yield
FCF Yield for TSCAN THERAPEUTICS INC is calculated as follows: FCF [ $ -7.26M ] / Market Cap [ $ 0 ]
(=) FCF Yield [ 0% ]
Minimum
Mar 31, 2025
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.58K |
---|---|
min | -33.87% |
max | 37.55% |
average | 1.62% |
median | 3.25% |
std | 11.35% |